Resonance Specialtie

₹104.1 -2.1 | 2%

WEBSITE BSE:524218 NSE : RESONANCE 18 May, 12:50

Market Cap ₹120 Cr.

Stock P/E 40.4

P/B 2.2

Current Price ₹104.1

Book Value ₹ 46.6

Face Value 10

52W High ₹133.5

Dividend Yield 0.96%

52W Low ₹ 77

Edit Ratio

Resonance Specialtie Research see more...

Overview Inc. Year: 1989Industry: Chemicals

Resonance Specialtie Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Resonance Specialtie Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	19	16	16	15	9	18	13	10	15	16
Other Income	0	1	1	1	0	0	0	0	0	0
Total Income	19	17	17	16	9	19	14	10	16	17
Total Expenditure	14	13	14	14	8	17	12	9	14	15
Operating Profit	5	4	2	2	2	2	2	1	2	1
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	4	4	2	2	1	2	1	1	1	1
Provision for Tax	1	1	1	0	0	0	0	0	0	0
Profit After Tax	3	3	2	1	1	1	1	0	1	1
Adjustments	-0	-0	0	0	0	0	-0	0	0	-0
Profit After Adjustments	3	3	2	1	1	1	1	0	1	1
Adjusted Earnings Per Share	2.9	2.5	1.3	1.2	0.8	1.1	0.8	0.4	0.8	0.6

Resonance Specialtie Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	40	45	38	39	34	36	40	56	70	76	59	54
Other Income	0	0	1	0	1	1	1	2	2	1	2	0
Total Income	40	46	39	39	35	37	42	58	72	77	60	57
Total Expenditure	37	43	37	36	32	35	35	48	56	59	52	50
Operating Profit	3	3	2	3	3	2	6	10	16	18	8	6
Interest	1	1	1	1	0	1	1	0	0	0	0	0
Depreciation	1	1	1	1	1	1	1	1	1	2	1	0
Exceptional Income / Expenses	-0	-0	1	0	0	-0	-0	-1	0	0	0	0
Profit Before Tax	1	1	1	2	1	0	5	7	15	16	7	4
Provision for Tax	0	0	0	0	0	1	2	1	4	4	2	0
Profit After Tax	0	1	1	1	1	-1	3	6	11	12	5	3
Adjustments	0	0	0	0	0	0	-0	0	0	0	0	0
Profit After Adjustments	0	1	1	1	1	-1	3	6	11	12	5	3
Adjusted Earnings Per Share	0.4	0.9	1.1	1	0.9	-0.6	2.8	4.8	9.1	10.7	4.3	2.6

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-22%	2%	10%	4%
Operating Profit CAGR	-56%	-7%	32%	10%
PAT CAGR	-58%	-6%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	25%	-8%	37%	26%
ROE Average	10%	25%	23%	13%
ROCE Average	14%	34%	32%	19%

Resonance Specialtie Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	21	21	21	23	24	23	26	31	41	52	56
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	0	0	0	0	0	0	0	0	0	0	2
Other Non-Current Liabilities	3	3	1	1	1	2	2	2	2	2	2
Total Current Liabilities	9	10	12	8	15	12	10	9	12	3	7
Total Liabilities	33	34	35	32	40	37	38	41	55	57	66
Fixed Assets	17	15	14	14	15	15	14	14	16	14	20
Other Non-Current Assets	0	0	0	1	2	2	2	3	1	1	1
Total Current Assets	16	18	20	17	23	20	22	24	38	42	45
Total Assets	33	34	35	32	40	37	38	41	55	57	66

Resonance Specialtie Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	1	0	2	1	1	1	1	2	2	6	9
Cash Flow from Operating Activities	1	2	1	3	1	2	5	1	4	13	-8
Cash Flow from Investing Activities	0	-0	-0	-1	-3	-1	-1	-2	-1	-9	3
Cash Flow from Financing Activities	-1	-1	-2	-2	2	-1	-4	1	0	-2	1
Net Cash Inflow / Outflow	-0	1	-1	0	-0	0	1	1	3	3	-4
Closing Cash & Cash Equivalent	0	2	1	1	1	1	2	2	6	9	4

Resonance Specialtie Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	0.4	0.89	1.11	1.03	0.89	-0.6	2.78	4.77	9.12	10.71	4.33
CEPS(Rs)	1.39	1.84	2.11	2	1.81	0.39	3.56	5.57	9.97	12.22	5.61
DPS(Rs)	0	0.5	0.5	0	0	0	0	1	1	1	1
Book NAV/Share(Rs)	12.93	13.23	13.74	14.77	15.88	15.27	18.05	21.57	30.35	40	43.37
Core EBITDA Margin(%)	5.29	5.56	3.15	7.29	5.41	1.66	10.62	12.17	18.31	19.7	10.36
EBIT Margin(%)	3.38	3.4	4.94	5.21	4.81	1.76	11.65	11.41	19.08	19.23	10.57
Pre Tax Margin(%)	1.53	2.16	3.48	3.96	3.75	0.34	10.47	10.86	18.7	19.15	10.41
PAT Margin (%)	1.12	2.14	3.22	2.88	2.77	-1.79	7.05	8.64	13.52	14.54	7.6
Cash Profit Margin (%)	3.94	4.45	6.13	5.57	5.63	1.16	9.05	10.08	14.78	16.59	9.84
ROA(%)	1.39	3.05	3.72	3.56	2.85	-1.81	8.54	13.89	21.98	22.19	8.16
ROE(%)	3.1	6.79	8.2	7.24	5.8	-3.86	16.66	24.08	35.11	30.44	10.39
ROCE(%)	7.58	8.79	10.41	11.37	8.62	3.14	25.29	31.51	48.33	39.75	14.14
Receivable days	62.87	65.48	91.03	76.13	70.95	66.07	57.12	39.24	36.46	37.82	56.93
Inventory Days	56.21	49.36	62.16	68.54	106.26	110.4	75.54	63.74	70.23	60.6	96.41
Payable days	64.61	65.67	102.49	119.03	199.93	165.24	130.07	116.55	107.26	72.52	84.83
PER(x)	36.13	12.04	14.84	19.28	45.44	0	7.31	5.29	13.76	16.47	17.9
Price/Book(x)	1.1	0.81	1.19	1.35	2.54	1.85	1.12	1.17	4.13	4.41	1.79
Dividend Yield(%)	0	4.67	3.05	0	0	0	0	3.96	0.8	0.57	1.29
EV/Net Sales(x)	0.49	0.31	0.56	0.62	1.47	0.99	0.54	0.48	1.99	2.57	1.49
EV/Core EBITDA(x)	7.68	4.92	9.93	7.34	17.64	19.14	3.5	2.81	8.84	10.78	10.37
Net Sales Growth(%)	11.1	14.45	-16.1	2.4	-12.16	5.2	11.96	39.43	25.21	7.78	-22.36
EBIT Growth(%)	0	17.99	20.36	10.15	-17.39	-61.75	676.45	37.42	104.19	10.1	-57.46
PAT Growth(%)	185.69	124.89	24.36	-6.63	-13.83	-167.63	561.68	71.86	91.08	17.44	-59.54
EPS Growth(%)	185.7	124.87	24.36	-6.63	-13.84	-167.63	561.68	71.86	91.08	17.44	-59.54
Debt/Equity(x)	0.23	0.22	0.2	0.11	0.22	0.19	0	0.02	0.03	0	0.04
Current Ratio(x)	1.82	1.85	1.7	2.03	1.58	1.71	2.28	2.78	3.12	12.52	6.7
Quick Ratio(x)	1.04	1.26	1.05	1.08	0.65	0.87	1.35	1.21	1.75	9.02	3.23
Interest Cover(x)	1.83	2.74	3.38	4.16	4.52	1.24	9.88	20.53	51.15	238.42	65.09
Total Debt/Mcap(x)	0.21	0.27	0.16	0.08	0.09	0.1	0	0.02	0.01	0	0.02

Resonance Specialtie Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	62.31	54.25	54.25	54.25	54.25	54.25	54.25	54.25	54.25	54.25
FII	0.23	0.23	0.23	0.23	0.23	0.23	0	0	0	0
DII	0.03	0.03	0.03	0	0.03	0.03	0.03	0.03	0.03	0.03
Public	37.42	45.49	45.49	45.52	45.49	45.49	45.72	45.72	45.72	45.72
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.72	0.63	0.63	0.63	0.63	0.63	0.63	0.63	0.63	0.63
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.43	0.53	0.53	0.53	0.53	0.53	0.53	0.53	0.53	0.53
Others	0	0	0	0	0	0	0	0	0	0
Total	1.15	1.15	1.15	1.15	1.15	1.15	1.15	1.15	1.15	1.15

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 25%
Company is almost debt free.

Cons

Debtor days have increased from 72.52 to 84.83days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.